Formation of Tau RNA Complexes disrupts tau function and drives tau neuropathology
Tau RNA 复合物的形成会破坏 tau 功能并驱动 tau 神经病理学
基本信息
- 批准号:10777174
- 负责人:
- 金额:$ 63.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-30 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffinityAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAmyloidAutomobile DrivingBindingBiological ModelsBrainBrain DiseasesCaenorhabditis elegansCellsCessation of lifeCharacteristicsClinical TrialsCognitiveComplexDataDementiaDepositionDiagnosticDiseaseFrontotemporal Lobar DegenerationsFunctional disorderGenesHomeostasisHumanImpaired cognitionInterventionKnowledgeLesionMapsMeasuresMediatingMediatorMessenger RNAMicrotubule PolymerizationMicrotubule StabilizationMicrotubulesMolecularMolecular ConformationMolecular WeightMonitorMonoclonal AntibodiesNerve DegenerationNeuronal DysfunctionNeuronsOutcomePathogenesisPathologicPathologyPathway interactionsPoly(A) TailPoly(A)+ RNAPredispositionPropertyProtein IsoformsProteinsRNARNA BindingRNA Recognition MotifRNA-Binding ProteinsReporterRoleSeveritiesSpecificitySystemTauopathiesTherapeuticToxic effectTransgenesTubulinWorkbrain tissuedisabilityin vivomouse modelneuropathologypolyadenylated messenger RNApre-clinicalpreservationsymptom treatmenttargeted treatmenttau Proteinstau aggregationtau conformationtau functiontau mutationtherapeutic developmenttool
项目摘要
Pathological tau protein accumulates in neuronal lesions and constitutes one of the defining
diagnostic hallmarks of Alzheimer’s disease and related tauopathy disorders. Tau neuropathology correlates
with severity of dementia in Alzheimer’s disease. However, tau related dysfunction and aggregation drives
neurodegenerative changes by an incompletely understood molecular mechanism. Previous work has
demonstrated that RNA binding proteins impact tau function and aggregation in model systems and disease
states. In quantitative studies, we have shown that tau binds RNA with high affinity but low sequence specificity.
Tau RNA complexes (TRCs) form high molecular weight oligomeric tau species that may be on pathway to
formation of mature fibrillar aggregates. We have produced a TRC recognizing monoclonal antibody (TRC35)
that detects a disease relevant pathological tau conformation. We hypothesize that RNA and microtubules (MTs)
compete for tau binding with TRC formation driving neuropathological tau accumulation, fibril deposition, and
neurodegeneration while MT binding promotes neuronal homeostasis. We propose 3 specific aims to determine
the impact of tau RNA binding activity on disease pathogenesis. We will 1) dissect the molecular features of
tau RNA binding activity and interplay with tau microtubule binding activity; 2) map the abundance,
distribution, and composition of TRC35+ lesions in tauopathy disorders; and 3) measure the impact of
tau RNA complex formation on neurodegeneration. Completion of the proposed project will impact the field
by integrating tau RNA binding functions with known tau roles in MT stabilization. We will also gain significant
understanding of the molecular mechanisms involved in disease relevant pathological tau aggregation and
deposition in tauopathy disorders. We will further measure the contribution of tau/RNA complexes to the
neurodegeneration observed in tauopathies.
病理性tau蛋白在神经元损伤中积聚,构成了
阿尔茨海默病和相关的肌萎缩侧索硬化症的诊断特征。Tau神经病理与
与阿尔茨海默病的痴呆症严重程度有关。然而,tau相关的功能障碍和聚集驱动
神经退行性改变的分子机制还不完全清楚。以前的工作有
证明RNA结合蛋白在模型系统和疾病中影响tau的功能和聚集
各州。在定量研究中,我们已经证明tau以高亲和力但低序列特异性结合RNA。
Tau RNA复合体(Trc)形成高分子量低聚tau物种,它可能在途径上
形成成熟的纤维状聚集体。我们研制了一种可识别TRC的单抗(TRC35)。
检测到与疾病相关的病理tau构象。我们假设RNA和微管(MT)
与TRC形成竞争tau结合,驱动神经病理性tau堆积、纤维沉积和
神经退行性变,而MT结合促进神经元动态平衡。我们提出了三个具体目标来确定
Tau RNA结合活性在疾病发病机制中的影响。我们将1)剖析它的分子特征
Tau RNA结合活性及其与tau微管结合活性的相互作用;2)绘制丰度图,
TRC35+病变在肌萎缩侧索硬化症中的分布和组成;以及3)测量
Tau RNA复合体的形成对神经退变的影响。拟议项目的完成将对该油田产生影响
通过整合tau RNA结合功能和已知的tau在MT稳定中的作用。我们还将获得显著的收益
了解与疾病相关的病理性tau聚集和
肌张力障碍中的沉积。我们将进一步测量tau/RNA复合体对
在神经官能症中观察到的神经变性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian C. Kraemer其他文献
Erratum to: Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression
- DOI:
10.1186/s13024-015-0051-6 - 发表时间:
2015-10-23 - 期刊:
- 影响因子:17.500
- 作者:
Xi Chen;Hannah V. McCue;Shi Quan Wong;Sudhanva S. Kashyap;Brian C. Kraemer;Jeff W. Barclay;Robert D. Burgoyne;Alan Morgan - 通讯作者:
Alan Morgan
TMEM106B C-terminal fragments aggregate and drive neurodegenerative proteinopathy
TMEM106B C 端片段聚集并驱动神经退行性蛋白病
- DOI:
10.1101/2024.06.11.598478 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Ruben Riordan;Aleen D. Saxton;P. McMillan;Rebecca L. Kow;Nicole F. Liachko;Brian C. Kraemer - 通讯作者:
Brian C. Kraemer
Yeast three-hybrid system to detect and analyze RNA-protein interactions.
用于检测和分析 RNA-蛋白质相互作用的酵母三杂交系统。
- DOI:
- 发表时间:
2000 - 期刊:
- 影响因子:0
- 作者:
Beilin Zhang;Brian C. Kraemer;D. Sengupta;S. Fields;Marvin Wickens - 通讯作者:
Marvin Wickens
α-Methyl-α-phenylsuccinimide ameliorates neurodegeneration in a <em>C. elegans</em> model of TDP-43 proteinopathy
- DOI:
10.1016/j.nbd.2018.06.013 - 发表时间:
2018-10-01 - 期刊:
- 影响因子:
- 作者:
Shi Quan Wong;Matthew G. Pontifex;Marie M. Phelan;Chandra Pidathala;Brian C. Kraemer;Jeff W. Barclay;Neil G. Berry;Paul M. O'Neill;Robert D. Burgoyne;Alan Morgan - 通讯作者:
Alan Morgan
Alternative 3′ UTR polyadenylation is disrupted in the rNLS8 mouse model of ALS/FTLD
- DOI:
10.1186/s13041-025-01174-1 - 发表时间:
2025-01-14 - 期刊:
- 影响因子:2.900
- 作者:
Randall J. Eck;Paul N. Valdmanis;Nicole F. Liachko;Brian C. Kraemer - 通讯作者:
Brian C. Kraemer
Brian C. Kraemer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian C. Kraemer', 18)}}的其他基金
Targeting MSUT2 with small molecules to ameliorate pathological tau
用小分子靶向 MSUT2 改善病理性 tau
- 批准号:
10735826 - 财政年份:2023
- 资助金额:
$ 63.88万 - 项目类别:
Developing MSUT2 Nanobodies for Targeting Pathological Tau in Alzheimer's Disease
开发 MSUT2 纳米抗体来靶向阿尔茨海默病中的病理性 Tau 蛋白
- 批准号:
10518408 - 财政年份:2022
- 资助金额:
$ 63.88万 - 项目类别:
Developing MSUT2 Nanobodies for Targeting Pathological Tau in Alzheimer's Disease
开发 MSUT2 纳米抗体来靶向阿尔茨海默病中的病理性 Tau 蛋白
- 批准号:
10363866 - 财政年份:2022
- 资助金额:
$ 63.88万 - 项目类别:
Reversal of Tau Pathology with MSUT2 siRNA Conjugates
使用 MSUT2 siRNA 缀合物逆转 Tau 病理学
- 批准号:
10240452 - 财政年份:2020
- 资助金额:
$ 63.88万 - 项目类别:
Reversal of Tau Pathology with MSUT2 siRNA Conjugates
使用 MSUT2 siRNA 缀合物逆转 Tau 病理学
- 批准号:
9909831 - 财政年份:2020
- 资助金额:
$ 63.88万 - 项目类别:
Protection from pathological tau by activation of the ER unfolded protein response
通过激活 ER 未折叠蛋白反应来预防病理性 tau 蛋白
- 批准号:
10347310 - 财政年份:2020
- 资助金额:
$ 63.88万 - 项目类别:
Protection from pathological tau by activation of the ER unfolded protein response
通过激活 ER 未折叠蛋白反应来预防病理性 tau 蛋白
- 批准号:
10551219 - 财政年份:2020
- 资助金额:
$ 63.88万 - 项目类别:
Protection from pathological tau by activation of the ER unfolded protein response
通过激活 ER 未折叠蛋白反应来预防病理性 tau 蛋白
- 批准号:
9901055 - 财政年份:2020
- 资助金额:
$ 63.88万 - 项目类别:
Inhibiting pathological TDP-43 phosphorylation as a therapeutic strategy for ALS
抑制病理性 TDP-43 磷酸化作为 ALS 的治疗策略
- 批准号:
9348132 - 财政年份:2017
- 资助金额:
$ 63.88万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 63.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 63.88万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 63.88万 - 项目类别:
Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 63.88万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 63.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 63.88万 - 项目类别:
Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 63.88万 - 项目类别:
Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 63.88万 - 项目类别:
Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
- 批准号:
498278 - 财政年份:2024
- 资助金额:
$ 63.88万 - 项目类别:
Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
- 批准号:
24K04938 - 财政年份:2024
- 资助金额:
$ 63.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




